Geron Competitors and Similar CompaniesClear all
Geron's competitors and similar companies include Olema Oncology, Scorpion Therapeutics, Odyssey Therapeutics and Five Prime Therapeutics.
 Geron Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. |  Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. | ||
Founding Date | Founding Date 1990 | Founding Date 2007 | Founding Date 2020 | Founding Date 2021 | Founding Date 2001 |
Type | Type Public | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Foster City, US HQ Parsippany Troy Hills, US Louisville, US | Locations San Francisco, US HQ San Francisco, US | Locations Boston, US HQ Boston, US South San Francisco, US | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US | Locations South San Francisco, US HQ |
Employees | Employees 1713% increase | Employees 9630% increase | Employees 1213% decrease | Employees 1481% decrease | Employees 5141% decrease |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 679.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($83.5m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($84.3m) (FY, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 96.7m | Total funding raised $ 145.1m | Total funding raised $ 108m | Total funding raised $ 386m | Total funding raised $ 237.2m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company
Scorpion Therapeutics
HQ
Boston, US
Employees
121↓ 3% decrease
Scorpion Therapeutics is a company that develops cancer treatments.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View companyFive Prime Therapeutics
HQ
South San Francisco, US
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
View company